NIMBLE Diagnostics, SL
-
Location
Hall 7 Stand 7J6
Information
NIMBLE Diagnostics is a Barcelona-based MedTech company developing a new way to monitor medical implants from outside the body.
Our first product, WAEVE, is a non-invasive, non-ionising platform that uses radiofrequency sensing, advanced signal processing and AI to read the electromagnetic response of implanted devices, starting with coronary stents.
Unlike smart implants, WAEVE does not require chips, batteries or modification of the implant. It works by exploiting the implant’s own electromagnetic properties, enabling existing devices to become readable sources of clinical information.
NIMBLE is currently in clinical-stage development, with human validation underway and a roadmap toward regulatory approval and commercial launch.
Our long-term vision is to create a new diagnostic layer for the increasingly implanted patient, extending beyond coronary stents to cardiovascular and orthopaedic implants and redefining how medicine interacts with technology inside the human body.
Our first product, WAEVE, is a non-invasive, non-ionising platform that uses radiofrequency sensing, advanced signal processing and AI to read the electromagnetic response of implanted devices, starting with coronary stents.
Unlike smart implants, WAEVE does not require chips, batteries or modification of the implant. It works by exploiting the implant’s own electromagnetic properties, enabling existing devices to become readable sources of clinical information.
NIMBLE is currently in clinical-stage development, with human validation underway and a roadmap toward regulatory approval and commercial launch.
Our long-term vision is to create a new diagnostic layer for the increasingly implanted patient, extending beyond coronary stents to cardiovascular and orthopaedic implants and redefining how medicine interacts with technology inside the human body.